Zuranolone is the first oral drug specifically designed for severe depression after childbirth, with relief that starts on Day 3 of a two-week regimen, according to clinical trial results.
Healthcare providers should discuss all available treatment options that have evidence of benefit with individuals living with type 1 diabetes, including DIY options.